Clinical Trial Update: Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder [Phase 2]

View source ↗

Summary

This Phase 2 study reports pharmacokinetics and tolerability of vortioxetine in children and adolescents with depressive or anxiety disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Depressive Disorder, Anxiety Disorder | Phase 2 | Status: COMPLETED | Results posted: 2016-01-15